Global Supply Chain Volatility: 2022 Outlook
Amidst historic production disruption, shortages and low levels of inventory, manufacturers, distributors and retailers have been adapting business strategy real-time in response to continued volatility. There has been a rising shift in automation of distribution processes across industries as these businesses seek to profitably operate despite supply chain instability and margin pressures. Automated, real-time insights have helped suppliers remain competitive, providing direct information at every stage before a product reaches the consumer and ensuring optimal customer experience (CX) even when supply chain disruption may lead to delays.
Surprisingly, today’s supply chain issues have not dented private equity (PE) appetite. Buyers continue to engage in the space but have increasingly altered diligence processes to discern whether potential targets will stabilize in line with the broader supply chain normalization expected in 2023, or if they will face long-term effects from inventory shortages, lack of automation and other issues. In general, the deal parties are leveraging a case-by-case approach to navigating supply chain nuances and issues for each industry—viewing mergers and acquisitions (M&A) as more of an art than an exact science. While there have been some delays, deals are largely completing with great outcomes.
Lincoln International compiled industry-specific insights as supply chain adjusts and stabilizes.
- Click here to download a printable version of this perspective.
- Sign up to receive Lincoln's perspectives
In addition to the universal supply chain issues, there are challenges unique to individual regions and countries.
|Europe: Already burdened by the pandemic and existing supply chain challenges, the semiconductor industry is experiencing additional setbacks due to unrest in Ukraine. Ukraine is a leading supplier of neon gas, a key component of the lasers used in a phase of semiconductor fabrication. Further, Ukraine supplies gases required for chip manufacturing (xenon and krypton). The conflict has caused the depletion of semiconductor and chip reserves, already an issue, calling for companies to begin sourcing these materials from alternative suppliers.
Asia: China is currently experiencing a severe COVID-19 outbreak, with reported cases rising to levels not seen since the early days of the pandemic. With strict lockdowns in effect, ships are not leaving their ports. Even if the number of positive cases decreases in the near-term, the delay in goods leaving for distribution will have a ripple effect throughout the remainder of the year.
United States: Once the goods leave Asia, issues at ports on the West Coast of the U.S. could create further delays. In May, dockworkers and cargo-handling companies for about 22,400 workers at 29 ports entered contract negotiations. Depending on how the labor negotiations progress, there could be repercussions. During the last rounds of negotiations in 2002 and 2014, not only was the distribution of goods delayed, manufacturers and retailers lost significant revenue.
Looking ahead, supply chain volatility is not apt to have a long-term effect. As COVID-19 restrictions recede and interest rate increases manage inflation, the supply chain will adjust and stabilize. Lincoln International compiled industry-specific insights as players work to remain agile and competitive throughout the supply chain crisis and in the years to come.
|Consumer: While consumer demand has shown some recent softening, current spending remains above historic levels. However, labor constraints, limited storage space and extended delivery times are all expected to continue for shippers in the coming year. Additionally, significantly increased shipping costs continue to drive short-term margin pressure, which we expect will result in longer-term price increases. For companies looking to minimize the supply chain’s impact on revenue, investments in additional capacity-integrating technology are advised to help drive lower costs and greater stabilization across company supply chains.|
|Automotive & Truck: While many automotive market participants hesitated to pursue a sale in 2021, as the supply chain begins to normalize, Lincoln forecasts that these players will begin revisiting M&A opportunities in the coming years and we expect 2022 will be an especially active year for the sale of non-core businesses. To combat the present supply chain instability, automakers are increasingly shifting toward sourcing local suppliers to mitigate supply chain risks and delays. To maximize stability and risk mitigation efforts, Lincoln also recommends that automakers, specifically original equipment manufacturers (OEMs), work to meet heightened consumer demand levels through approaches such as geographic expansion in local markets.|
|Logistics & Transportation: The significant disruption and capacity constraints at each leg of the supply chain, along with shifting requirements and increased complexity driven by surging online spending is driving significant consolidation in the sector — especially as providers seek to expand service capabilities, increase controlled capacity and build scale. In recent years, logistics and transportation providers have benefited from a favorable supply / demand imbalance, ultimately driving record levels of profitability for many, especially so for those with greater network capacity. Rising labor, fuel and other significant input costs coupled with softening consumer spending on hard goods has resulted in some near-term volatility with freight rates as supply and demand dynamics become more normalized. Investors are increasingly focusing on determining a target’s sustainable level of earnings once supply / demand dynamics equalize. We recommend that sellers proactively prepare for these discussions with dynamic scenario planning analyses in place.|
|Healthcare: Throughout the pandemic, it has been especially critical to mitigate and resolve any supply chain delays related to all aspects of pharmaceutical manufacturing. Amidst a highly contagious disease, the healthcare sector has seen sky-high demand for medication, medical services and treatments. As drugs become exceedingly specialized and complex to manufacture, pharma has increasingly relied on external strategic partners to outsource development and ensure long-term product capacity. With increased outsourcing, we don’t forecast an eventual return to full in-house development. In addition, with growing focus on adoption of China Plus One sourcing strategies, we expect dual or tri-sourcing tactics will continue to gain pace in the coming years and will become the default position across many pharmaceutical portfolios.|
|Industrials: Industrials businesses are also no stranger to the present supply chain challenges as they have been navigating trade tariffs over the last several years. In the past, utilizing OEM relationships and overbuying raw materials in anticipation of supply shortages has proven successful in the sector. In combating the great resignation, many players are increasingly implementing automation as one way to circumvent labor shortages and rising labor costs.|
The ability to position clients so they can realize value and achieve their goals is what inspires me.
Managing Director | Co-head of EuropeLondon
Meet Professionals with Complementary Expertise in M&A
I am enthusiastic about creating sustainable growth and the highest value for our clients, and strive to leave a positive footprint beyond any successful M&A transaction.
Managing Director | Management Board MemberFrankfurt
I enjoy leading clients and realizing their objectives, while structuring solutions to issues that are both intriguing and challenging.
Managing Director | Head of SwitzerlandZurich
I am inspired by working with entrepreneurs and innovators who feel passionately about what they are creating.
Managing DirectorSan Francisco
Related Perspectives in M&A
Cybersecurity Report: Q2 2023
Consecutive quarterly sector mergers and acquisitions (M&A) deal activity rose in Q2 2023 to 54 cybersecurity transactions, from 49 in Q1 2023. Q2 M&A volume of $2.4 billion was roughly… Read More
HealthInvestor | CMA Launches Review of Vet Sector
Originally posted by HealthInvestor on September 7, 2023. The Competition and Markets Authority (CMA) has begun reviewing UK veterinary services to uncover how well the market is working for pet… Read More
Real Deals | Finding Opportunities Amid Uncertainty
Originally posted by Real Deals on September 1, 2023. European deal activity in the first half of 2023 has been slower, but activity in the second half of the year… Read More
Conceiving Success: Growth and Consolidation in IVF in APAC and the Middle East
In-vitro fertilization in Asia-Pacific and the Middle East is growing quickly due to several factors; the industry’s rapid growth offers an opportunity for investors to capitalize on momentum. In a… Read More
Recent Transactions in M&A
Lincoln International advised EV Private Equity on the sale of Bluware to Computer Modelling Group
Lincoln International advised The Beekman Group on the sale of GED Integrated Solutions to MSouth Equity Partners
Lincoln International advised Havencrest Capital Management on its majority investment in Tekton Research
Lincoln International advised Mutares on the sale of Special Melted Products to Cogne Accial Speciali, a subsidiary of Walsin Lihwa
Lincoln International advised Chequers Capital on its agreement to acquire Cheops from Indufin
Lincoln International advised Your Way Medicare on its sale to Accretive, a portfolio company of GTCR
Lincoln International advised Industrial Growth Partners on the sale of Des-Case Corporation to The Timken Company
Lincoln International advised e-Attestations on its sale of a minority stake to Keensight Capital